Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (831)
|
Core Tip (863)
|
Full Article (HTML) (3258)
|
Full Article (PDF)-777K (563)
|
Audio-357K (35)
|
Peer-Review Report-122K (129)
|
Answering Reviewers-64K (157)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (9145)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications
World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1001)
|
Core Tip (978)
|
Full Article (HTML) (9592)
|
Figures (1-4) (842)
|
Full Article (PDF)-948K (1228)
|
Audio-1310K (25)
|
Peer-Review Report-106K (320)
|
Answering Reviewers-19K (200)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (47)
|
Total Visits (20074)
|
Similar Articles (454)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model
World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (929)
|
Core Tip (925)
|
Full Article (HTML) (4017)
|
Figures (1-2) (158)
|
Tables (1-2) (139)
|
Full Article (PDF)-1246K (656)
|
Audio-442K (31)
|
Peer-Review Report-131K (260)
|
Answering Reviewers-120K (169)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (13789)
|
Similar Articles (15)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?
World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (879)
|
Core Tip (843)
|
Full Article (HTML) (2817)
|
Figures (1-3) (133)
|
Tables (1-1) (139)
|
Full Article (PDF)-814K (459)
|
Audio-757K (20)
|
Peer-Review Report-105K (202)
|
Answering Reviewers-109K (179)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (12360)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (890)
|
Core Tip (879)
|
Full Article (HTML) (3334)
|
Tables (1-3) (121)
|
Full Article (PDF)-799K (414)
|
Audio-1969K (20)
|
Peer-Review Report-132K (183)
|
Answering Reviewers-50K (154)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (11373)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open